Cargando…
Obstetric and neonatal outcomes after programmed frozen embryo transfer with or without GnRH agonist for polycystic ovary syndrome: secondary analysis results from a randomized controlled trial
BACKGROUND: Recent studies have reported higher risks of adverse maternal and neonatal outcomes, such as hypertensive disorders of pregnancy, after programmed frozen embryo transfer, especially in cycles with gonadotropin-releasing hormone agonist pretreatment. It remains unclear if GnRH agonist pre...
Autores principales: | Jie, Hui-ying, Hu, Ruifang, Zhang, Limei, Dong, Kexin, Wu, Chunyan, Wang, Qiong, Luo, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165264/ https://www.ncbi.nlm.nih.gov/pubmed/37168544 http://dx.doi.org/10.1016/j.xagr.2023.100201 |
Ejemplares similares
-
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012) -
Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles
por: Choi, Min Hye, et al.
Publicado: (2012) -
The Role of GnRH Receptor Autoantibodies in Polycystic Ovary Syndrome
por: Kem, David C, et al.
Publicado: (2020) -
Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
por: Yang, Wen-Jui, et al.
Publicado: (2009) -
Targeting Elevated GnRH Pulsatility to Treat Polycystic Ovary Syndrome
por: Abbara, Ali, et al.
Publicado: (2021)